No takes yet. Share an insight, caveat, or question.
Systematic review reveals onabotulinum toxin A effectively reduces post-traumatic headache symptoms in diverse populations, highlighting its potential over traditional treatments.
Atwan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: